UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women

Maturitas, 2002-11, Vol.43 (3), p.207-214

2002

Volltextzugriff (PDF)

In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer

The Journal of steroid biochemistry and molecular biology, 2001-06, Vol.77 (4), p.271-279

2001

Volltextzugriff (PDF)

Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations

Cancer chemotherapy and pharmacology, 2006-03, Vol.57 (3), p.335-342

2006

Volltextzugriff (PDF)

Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selective estrogen-receptor modulator

European journal of clinical pharmacology, 2000-09, Vol.56 (6-7), p.469-475

2000

Volltextzugriff (PDF)

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors

Journal of clinical oncology, 1992-06, Vol.10 (6), p.990-994

1992

Volltextzugriff (PDF)

Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women

Menopause (New York, N.Y.), 2005-01, Vol.12 (2), p.202

2005

Volltextzugriff (PDF)

Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1359-1364

1989

Volltextzugriff (PDF)

Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth

JNCI : Journal of the National Cancer Institute, 1999-03, Vol.91 (5), p.474

DeGregorio, M W

1999

Volltextzugriff (PDF)

Intrinsic reactivity of tamoxifen and toremifene metabolites with DNA

Breast cancer research and treatment, 1998-07, Vol.50 (2), p.135-141

1998

Volltextzugriff (PDF)

Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in chinese hamster ovary cells resistant to the drug

Cancer research (Chicago, Ill.), 1986-12, Vol.46 (12), p.6242-6245

1986

Volltextzugriff (PDF)

Tamoxifen resistance in breast cancer

Critical reviews in oncology/hematology, 1993-06, Vol.14 (3), p.173-188

1993

Volltextzugriff (PDF)

Tissue distribution of transdermal toremifene

Cancer chemotherapy and pharmacology, 1997, Vol.39 (6), p.513-520

1997

Volltextzugriff (PDF)

Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicin

Cancer chemotherapy and pharmacology, 1998, Vol.42 (5), p.363-366

1998

Volltextzugriff (PDF)

Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene

Breast cancer research and treatment, 2000-03, Vol.60 (1), p.63-70

2000

Volltextzugriff (PDF)

Clinical pharmacokinetics of toremifene

Clinical pharmacokinetics, 2000-11, Vol.39 (5), p.327-334

2000

Volltextzugriff (PDF)

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer

Journal of clinical oncology, 1986-12, Vol.4 (12), p.1787-1793

1986

Volltextzugriff (PDF)

Pharmacokinetics of selective estrogen receptor modulators

Clinical pharmacokinetics, 2003, Vol.42 (4), p.361-372

2003

Volltextzugriff (PDF)

Differential expression of ganglioside GD3 by human leukocytes and leukemia cells

Cancer research (Chicago, Ill.), 1984-11, Vol.44 (11), p.5262-5265

1984

Volltextzugriff (PDF)

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause

Clinical interventions in aging, 2014-01, Vol.9, p.1939-1950

2014

Volltextzugriff (PDF)

Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer

Cancer chemotherapy and pharmacology, 1990-01, Vol.25 (4), p.247-251

1990

Volltextzugriff (PDF)

High‐dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin‐2 in patients with metastatic melanoma

Cancer, 2001-08, Vol.92 (3), p.609-619

2001

Volltextzugriff (PDF)

Targeting chemosensitizing doses of toremifene based on protein binding

Cancer chemotherapy and pharmacology, 1993, Vol.31 (5), p.412-414

1993

Volltextzugriff (PDF)

Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cells

Breast cancer research and treatment, 1992-01, Vol.24 (1), p.43-49

1992

Volltextzugriff (PDF)

Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California oncology group

Cancer chemotherapy and pharmacology, 1986-01, Vol.18 (3), p.235-238

1986

Volltextzugriff (PDF)

Estrogen priming in advanced breast cancer

Drug intelligence & clinical pharmacy, 1988-09, Vol.22 (9), p.672

1988

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(8)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(85)
Humans
(74)
Female
(48)
Biological And Medical Sciences
(47)
Medical Sciences
(46)
Oncology
(46)
Pharmacology. Drug Treatments
(39)
Animals
(33)
Antineoplastic Agents
(32)
Male
(25)
Chemotherapy
(20)
Pharmacology & Pharmacy
(20)
Mice
(16)
Tamoxifen - Analogs & Derivatives
(16)
Breast Neoplasms - Drug Therapy
(15)
Middle Aged
(14)
Toremifene
(14)
Adult
(13)
Cisplatin - Administration & Dosage
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women

In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer

Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations

Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selective estrogen-receptor modulator

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors

Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women

Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance

Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth

Intrinsic reactivity of tamoxifen and toremifene metabolites with DNA

Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in chinese hamster ovary cells resistant to the drug

Tamoxifen resistance in breast cancer

Tissue distribution of transdermal toremifene

Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicin

Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene

Clinical pharmacokinetics of toremifene

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer

Pharmacokinetics of selective estrogen receptor modulators

Differential expression of ganglioside GD3 by human leukocytes and leukemia cells

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause

Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer

High‐dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin‐2 in patients with metastatic melanoma

Targeting chemosensitizing doses of toremifene based on protein binding

Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cells

Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California oncology group

Estrogen priming in advanced breast cancer

Suchergebnisse filtern